Veru Inc (NASDAQ:VERU) insider Mitchell Shuster Steiner purchased 20,000 shares of Veru stock in a transaction dated Thursday, March 8th. The shares were purchased at an average price of $1.88 per share, with a total value of $37,600.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Mitchell Shuster Steiner also recently made the following trade(s):
- On Tuesday, March 6th, Mitchell Shuster Steiner purchased 20,000 shares of Veru stock. The shares were purchased at an average price of $1.50 per share, with a total value of $30,000.00.
Shares of Veru Inc (NASDAQ VERU) traded down $0.01 during trading on Friday, hitting $1.82. The stock had a trading volume of 166,682 shares, compared to its average volume of 97,178. The firm has a market cap of $97.39, a price-to-earnings ratio of -6.74 and a beta of 0.96. Veru Inc has a fifty-two week low of $0.90 and a fifty-two week high of $3.00.
VERU has been the subject of several research reports. ValuEngine lowered Veru from a “hold” rating to a “sell” rating in a report on Friday, November 17th. HC Wainwright set a $5.00 price target on Veru and gave the company a “buy” rating in a report on Tuesday, November 14th. Finally, Zacks Investment Research lowered Veru from a “hold” rating to a “strong sell” rating in a report on Saturday, January 6th.
TRADEMARK VIOLATION WARNING: “Insider Buying: Veru Inc (VERU) Insider Acquires 20,000 Shares of Stock” was first published by Markets Daily and is the property of of Markets Daily. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://www.themarketsdaily.com/2018/03/11/insider-buying-veru-inc-veru-insider-acquires-20000-shares-of-stock.html.
Veru Company Profile
Veru Inc, formerly The Female Health Company, is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector.
Receive News & Ratings for Veru Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru and related companies with MarketBeat.com's FREE daily email newsletter.